Maca Root — Research Profile

Different colors have different strengths. Black maca is best for male fertility, energy, and cognitive function. Red maca is best for prostate health, bone density, and menopausal symptoms. Yellow maca is the most common and most studied for general libido and mood. For comprehensive benefits, some products offer a tri-color blend.

Despite being commonly called a "hormonal balancer," clinical studies consistently show maca does NOT significantly alter testosterone, estrogen, FSH, or LH levels ^[1][2]. Its effects on libido, fertility, and menopausal symptoms appear to work through other mechanisms, possibly via macamides acting on the endocannabinoid system or through effects on neurotransmitters.

Gelatinization is a heat-extrusion process that removes the starch from maca, concentrating the bioactive compounds and making it much easier to digest. Raw maca can cause bloating and gas in many people due to its high starch content. Gelatinized maca is also more bioavailable, meaning you absorb more of the active compounds per gram.

Gelatinized maca, cooked to reduce starch for easier digestion, is the form used in most trials that reported benefits for sexual desire and menopausal symptoms. Raw powder has also been studied with similar outcomes, but no trial has directly compared gelatinized against raw, so a single best form cannot be claimed on evidence. Ecotype (yellow, red, or black) may matter biochemically but lacks comparative clinical testing.

The best-supported effect is a modest improvement in sexual desire in healthy men, seen with 1,500-3,000 mg/day of gelatinized maca and occurring without any change in testosterone or estradiol. A systematic review rated the overall evidence for sexual function as limited, with positive results in menopausal women and men but null results in cyclists. Separate reviews of menopause trials found favorable effects on Kupperman and Greene symptom scores while also judging the evidence limited and the safety unproven.

No standard dose is established. Trials showing a libido benefit in men used 1,500 mg or 3,000 mg/day of gelatinized maca, and menopause studies have used around 3-3.5 g/day, so most research clusters at roughly 1.5-3.5 g daily. Higher intakes have not shown added benefit and begin to raise tolerability concerns.

Timing of maca has not been directly studied; trials simply gave a fixed daily dose without comparing morning versus evening. Taking it with food is reasonable, since the main reported complaint is mild gastrointestinal upset. No evidence supports one time of day over another.

At about 3 g/day for 12 weeks, reported effects were transient and included gastrointestinal upset, headache, and irritability, and roughly 5 g/day of gelatinized maca produced mild GI disturbance. Isolated case reports describe vaginal bleeding, a manic episode, and restless legs syndrome, but these are rare and not clearly attributable to maca. Most trials found no effect on thyroid hormone panels.

Documented interaction data are very limited. The one notable report is a possible interaction with mianserin, a tetracyclic antidepressant, attributed to maca inhibiting the CYP3A4 enzyme, though concurrent medications clouded the picture. As a precaution, people taking drugs metabolized by CYP3A4 should raise maca with their prescriber before starting.

Maca is most reasonable for men seeking modest support for sexual desire and for perimenopausal or postmenopausal women targeting vasomotor and related symptoms, since those are the populations where small trials showed benefit. It is not a hormone replacement and did not change testosterone or estradiol in men. Pregnant and breastfeeding women should avoid it because human safety data are lacking.

In the one trial that tracked timing, 1,500-3,000 mg/day of gelatinized maca improved self-reported sexual desire in healthy men starting at 8 weeks, with no separation from placebo at 4 weeks. Most maca trials run 12 weeks or longer, so allow at least 6-8 weeks of daily use before judging an effect. Onset for menopausal or other uses has not been separately characterized.

Controlled trials have dosed maca daily for about 12 weeks, with some running to four months and the longest reaching roughly nine months, and the pharmacological review describes a good safety profile with no fatal adverse events reported. The systematic review of maca for menopausal symptoms, however, explicitly states that its safety "has not been proved yet," because the trials were small and short-term. Memorial Sloan Kettering's herb monograph similarly lists only subjective complaints such as altered menstrual cycles, moodiness, cramps, gastritis, and insomnia and documents no established long-term data, so there is no controlled evidence on continuous daily use beyond about a year.

No human upper limit has been set. A tolerability study using 0.6 g/kg/day of maca powder for 90 days recorded a moderate rise in the liver enzyme AST and in diastolic blood pressure, and about 5 g/day of gelatinized maca has caused mild gastrointestinal upset. At the other extreme, 115 g/day of fresh maca for 60 days produced no liver or kidney toxicity, so typical supplement doses of 1.5-3 g stay well below any level of concern.

There is very little research on combining maca with other supplements, and no trial has tested a maca-plus-supplement stack for added benefit. Maca itself did not alter testosterone or estradiol in men, so it has no obvious hormonal conflict with other products. Because interaction data are thin, add it on its own first so any GI upset or blood-pressure change can be attributed correctly.

Maca has no official standardization marker, so products are not standardized to a defined active compound the way some botanicals are. Most positive sexual-function and menopause trials used gelatinized (pre-cooked, starch-reduced) maca rather than raw powder, and the yellow, red, and black ecotypes differ chemically without head-to-head clinical comparisons. Favor products that specify the form and ecotype and that carry third-party purity testing.